Market closed·Syncing…
Market closed · Close · 19 Nov

Molbio Diagnostics Limited MOLBIOshare price and chart

Molbio Diagnostics closed at ₹1,526.40 on 19 November 2026, up 1.92% on the day. The range since listing is ₹926.35 to ₹1,686.80.

₹1,526.40The price one share last traded at, in rupees.+1.92% · ₹28.75
Low since listing ₹92679% up the rangeThe highest and lowest price the share has traded at in the past year, and where today's price sits between the two.high ₹1,687

Daily candlesEach candle is one trading day. The chart opens on the last year; drag back past the start or open full screen and the rest loads, back to listing (or the first day in our data). The body runs from the open to the close, the thin lines to the high and low. Green closed up, red closed down.

Loading prices…

Split and bonus adjusted daily candles. Drag back past the start, or open full screen, and its whole history loads. Scroll or pinch to zoom; full screen adds indicators, drawing and measuring.

Test a strategy on MOLBIO

Real prices, every charge counted. Pick one or write your own.

Technical snapshotHow the share has been behaving: its momentum, its trend, how much of the trading was real buying to keep, and its returns.

EOD 19 Nov
RSI (14) · 30 oversold, 70 overboughtA score from 0 to 100 showing how strong recent up days were against recent down days.
64.1Neutral
0 oversold3070overbought 100
Delivery · bought to hold vs churnOf all the shares traded in a day, the share that actually changed hands and went into someone's demat account, rather than being bought and sold the same day.
25.4%Near average
today 25.4%20d avg 20.7%

The share of traded quantity that was actually delivered (not squared off intraday) - high delivery vs its 20-session average suggests real buying or holding, not just churn.

vs 50 DMAHow far today's close is above or below the average closing price of the last 50 trading days. It shows the medium-term trend.+11.6%1 monthHow much the share price has changed over the period.+15.4%3 monthsHow much the share price has changed over the period.+47.2%Vol 30dHow much the share has actually been moving day to day, stated as a yearly percentage. 30% means it swung roughly 30% a year at that pace.64%

Returns and valuationWhat the market pays for this company and how well the business uses its money.

Books to 30 Sept 2026
Market capWhat the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality.₹17,590 Cr19 NovPrice to bookThe share price against the shareholders' money per share on the balance sheet. It asks what you pay for each rupee the owners have in the business.12.21xbooks of Sept 2026Dividend yieldThe cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share.0.00%last 12 monthsDebt to equityBorrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings.0.22xbooks of Sept 2026

What the numbers sayShort plain statements about this company's latest figures.

Written by fixed rules

Latest quarterIn the quarter to September 2026 (results filed 5 Nov 2026), sales was ₹259 cr and profit was ₹7.7 cr.

Nothing in the filings we hold crosses one of our rules yet. Each rule needs a few complete years of results, so recently listed companies often show nothing here.

Each line is written by a fixed rule from the company's own filings and share price, and names the figures it uses. It describes what happened; it is not advice about the share.

Shareholding patternThe share of the company held by its promoters, by foreign and domestic institutions, and by the public, quarter by quarter.

Who owns it
41.29%promoter holding, as of 2026-09-30+0.0 pts since 2026
Promoter share since listing
2026-0841.29% now, drawn to its own range2026-09
Who owns it todayas of Sep 26
41.3%
19.1%
38.0%
Promoter41.3%Foreign (FII)1.6%Domestic (DII)19.1%Public & others38.0%
Who is buying, who is leavingAug 26 to Sep 26
Promoter41.3%steady
Foreign (FII)1.6%+0.1 pts
Domestic (DII)19.1%+2.7 pts

Each line is that holder's share of all shares over the last 2 quarters, drawn to its own scale - the printed change is the size of the move. Mutual funds and insurers sit inside the domestic figure; hover the bar above for that split.

The promoter/promoter-group stake as a percentage of total shares, each quarter since listing. A rising line means promoters are adding to their stake; a falling one often means dilution, pledge-driven sales, or stake sales to new investors.

Recent announcementsThe company's own filings to the exchange in the last six months: results, board meetings, investor calls and more, each with its source document.

Last 6 months
Updates19-Nov-2026

Molbio Diagnostics Limited has informed the Exchange regarding 'Newspaper Advertisements for proposed Postal Ballot Notice and remote e-voting'.

Analysts/Institutional Investor Meet/Con. Call Updates11-Nov-2026

Molbio Diagnostics Limited has informed the Exchange about Transcript of Earnings Call with analysts and investors for the quarter and half year ended on September 30, 2026

Copy of Newspaper Publication09-Nov-2026

Molbio Diagnostics Limited has informed the Exchange about Copy of Newspaper Publication of Un-audited Financial Results (Standalone & Consolidated) for the quarter and half year ended September 30, 2026.

Monitoring Agency Report06-Nov-2026

Monitoring Agency Report on the utilization of proceeds raised through issuanceof equity shares by way of Public Issue of the Company

Analysts/Institutional Investor Meet/Con. Call Updates05-Nov-2026

Molbio Diagnostics Limited has informed the Exchange about Link of Recording of Earnings Call held on November 05,2026 for the quarter and half year ended September30, 2026.

Investor Presentation05-Nov-2026

Molbio Diagnostics Limited has informed the Exchange about Investor Presentation

Investor Presentation05-Nov-2026

Molbio Diagnostics Limited has informed the Exchange about Investor Presentation

Outcome of Board Meeting05-Nov-2026

Molbio Diagnostics Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.

Analysts/Institutional Investor Meet/Con. Call Updates02-Nov-2026

Molbio Diagnostics Limited has informed the Exchange about Schedule of meet

Spurt in Volume19-Oct-2026

Significant increase in volume has been observed in Molbio Diagnostics Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Molbio Diagnostics Limited has submitted their response.

Spurt in Volume16-Oct-2026

Significant increase in volume has been observed in Molbio Diagnostics Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.

Certificate under SEBI (Depositories and Participants) Regulations, 201808-Oct-2026

Molbio Diagnostics Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30,2026.

Trading Window28-Sep-2026

Molbio Diagnostics Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Outcome of Board Meeting25-Sep-2026

Molbio Diagnostics Limited has informed the Exchange regarding Outcome of Board Meeting held on September 25, 2026 for re-appointment of M/s K. S. Kamalakara & Co, Cost Accountants as the Cost Auditor of the Company for FY 2026-27.

Analysts/Institutional Investor Meet/Con. Call Updates17-Sep-2026

Molbio Diagnostics Limited has informed the Exchange about Schedule of meet to be held on Tuesday, September 22, 2026 at 11.00 A.M.(IST) onwards.

Backtest idea · MOLBIOMACD momentum

Momentum turning up, only while the long trend is up.

BuyMACD crosses above signal, price above 200-day SMA
SellMACD crosses back below
Real prices · every charge countedRun on MOLBIO
Backtest idea · MOLBIOLower band bounce

Buys a stretch below the usual range, sells on the way back.

BuyCloses below the lower Bollinger band
SellBack at the middle band, or 15 days
Real prices · every charge countedRun on MOLBIO
Backtest idea · MOLBIOSupertrend rider

Stays in while the trend line says up, out when it flips.

BuySupertrend turns up
SellSupertrend turns down
Real prices · every charge countedRun on MOLBIO
Your own ideaWrite a rule for MOLBIO in plain English“Buy MOLBIO when …”
Start writing
Buy the dip on MOLBIOBuy when RSI(14) drops below 30
52-week high breakout on MOLBIOBuy when closes at a 52-week high
Golden cross on MOLBIOBuy when 50-day EMA crosses above 200-day
Stochastic oversold on MOLBIOBuy when stochastic %K drops below 20
Pullback in an uptrend on MOLBIOBuy when RSI(14) below 40, price above 200-day EMA

Key ratios at a glanceThe eight figures most people check first, each placed against companies in the same industry.

Against its sector
Market capWhat the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality.
₹17,590 cr
Largest of 16 peers
sector middle ₹429 cr
Price to bookThe share price against the shareholders' money per share on the balance sheet. It asks what you pay for each rupee the owners have in the business.
12.2x
Highest of 14 peers
sector middle 2.3x
Debt to equityBorrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings.
0.22
Higher than 57% of 14 peers
sector middle 0.15
Dividend yieldThe cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share.
0.0%
Lower than 38% of 16 peers
sector middle 0.0%

Peers are the listed companies in the exchange's own industry group: Medical Equipment & Supplies. Balance-sheet figures are from the latest filed balance sheet; trends show each financial year we hold.

Backtest idea · MOLBIOStochastic oversold

Buys when the close sits near the bottom of its recent range.

BuyStochastic %K drops below 20
Sell8% profit, or after 15 days
Real prices · every charge countedRun on MOLBIO
Backtest idea · MOLBIOPullback in an uptrend

Buys a pause inside a rising trend.

BuyRSI(14) below 40, price above 200-day EMA
Sell8% profit, or after 30 days
Real prices · every charge countedRun on MOLBIO
Backtest idea · MOLBIOBuy the dip

Buys after a sharp fall, betting on a bounce.

BuyRSI(14) drops below 30
Sell10% profit, or after 20 days
Real prices · every charge countedRun on MOLBIO
Backtest idea · MOLBIO52-week high breakout

Buys strength, when the price makes a new one-year high.

BuyCloses at a 52-week high
Sell8% stop loss
Real prices · every charge countedRun on MOLBIO
Backtest idea · MOLBIOGolden cross

Follows the long trend: in when the fast average crosses above the slow one.

Buy50-day EMA crosses above 200-day
SellWhen it crosses back below
Real prices · every charge countedRun on MOLBIO
MACD momentum on MOLBIOBuy when MACD crosses above signal, price above 200-day SMA
Lower band bounce on MOLBIOBuy when closes below the lower Bollinger band
Supertrend rider on MOLBIOBuy when supertrend turns up
Buy the dip on MOLBIOBuy when RSI(14) drops below 30
52-week high breakout on MOLBIOBuy when closes at a 52-week high

Monthly price changeThe share's price change in every calendar month, one row per year, so you can check for yourself whether a month has a pattern.

Month by month
YearJanFebMarAprMayJunJulAugSepOctNovDecYear
2026
·
·
·
·
·
·
·
·
+20.5
-2.7
+19.8
·
+40.5%
3m
Monthly movebelow -10%-10 to -5-5 to -2-2 to 00 to +2+2 to +5+5 to +10above +10%month in progress

Month-on-month change in closing price, adjusted for splits and bonuses but not for dividends, so a large dividend shows up here as a fall. Starts from 1995, when the exchange began trading equities, or from the stock's listing if later. This is a record of what happened, not a forecast.

Deals and filingsLarge trades reported to the exchange, plus the company's documents sorted by type.

DatePartySideQuantityPriceValue
2026-09-16JUNOMONETA FINSOL PRIVATE LIMITED · bulkSELL5,91,823₹1,288.60₹76.26 Cr
2026-09-16JUNOMONETA FINSOL PRIVATE LIMITED · bulkBUY5,90,709₹1,288.14₹76.09 Cr
2026-09-11JUNOMONETA FINSOL PRIVATE LIMITED · bulkBUY12,33,175₹1,565.79₹193.09 Cr
2026-09-11JUNOMONETA FINSOL PRIVATE LIMITED · bulkSELL12,28,332₹1,566.94₹192.47 Cr
2026-09-11QE SECURITIES LLP · bulkBUY12,10,738₹1,542.36₹186.74 Cr
2026-09-11QE SECURITIES LLP · bulkSELL11,88,458₹1,552.02₹184.45 Cr
2026-09-11MICROCURVES TRADING PRIVATE LIMITED · bulkBUY7,53,493₹1,544.97₹116.41 Cr
2026-09-11MICROCURVES TRADING PRIVATE LIMITED · bulkSELL7,53,493₹1,545.88₹116.48 Cr

Read enough? Test MOLBIO. “Buy MOLBIO when RSI(14) drops below 30, sell at 10% profit or after 20 days.” Real prices, every charge counted.

Run it free